Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The objective of the study is to demonstrate the superiority of 0.1% octenidine mouthwash (Octenidin Mundspüllösung, OML) to placebo (PLAC) in the inhibition of plaque formation. The study will consist of a 14-day screening period and a 5-day treatment period.
Epistemonikos ID: dae849f1a6cf9da1b0dc147a1e48a852f771a13d
First added on: May 21, 2024